The historical rank and industry rank for Voyageur Pharmaceuticals's PB Ratio or its related term are showing as below:
During the past 13 years, Voyageur Pharmaceuticals's highest PB Ratio was 35.00. The lowest was 0.00. And the median was 0.00.
VYYRF's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.845 * Ranked among companies with meaningful PB Ratio only.
During the past 12 months, Voyageur Pharmaceuticals's average Book Value Per Share Growth Rate was -42.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -8.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Voyageur Pharmaceuticals was 40.10% per year. The lowest was -46.00% per year. And the median was -18.25% per year.
Back to Basics: PB Ratio
Voyageur Pharmaceuticals (OTCPK:VYYRF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Voyageur Pharmaceuticals PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where Voyageur Pharmaceuticals's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Voyageur Pharmaceuticals (VYYRF) has a PB Ratio of 31.67 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Voyageur Pharmaceuticals and its competitors. According to the industry distribution chart, Voyageur Pharmaceuticals ranks #909 out of 922 companies in the Drug Manufacturers industry, placing it in the top 98.6%.
Is Voyageur Pharmaceuticals' PB Ratio too high?
Voyageur Pharmaceuticals' current PB Ratio is 31.67. The Drug Manufacturers industry median PB Ratio is 1.85. Voyageur Pharmaceuticals' value of 31.67 is 1616.5% above this industry median. Based on the distribution chart, Voyageur Pharmaceuticals ranks #909 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Voyageur Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Voyageur Pharmaceuticals' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Voyageur Pharmaceuticals ranks #909 out of 922 companies for PB Ratio. This places Voyageur Pharmaceuticals in the lower half of its industry. The industry median PB Ratio is 1.85. Voyageur Pharmaceuticals' value of 31.67 is 1616.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.85, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Voyageur Pharmaceuticals's current PB Ratio of 31.67 is 1616.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Voyageur Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Voyageur Pharmaceuticals's current PB Ratio is 31.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyageur Pharmaceuticals stock overvalued right now?
Voyageur Pharmaceuticals (VYYRF) has a current PB Ratio of 31.67. The current PB Ratio is 31.67 and 1616.5% above the Drug Manufacturers industry median of 1.85. Voyageur Pharmaceuticals' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Voyageur Pharmaceuticals (VYYRF), the current PB Ratio is 31.67 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
18GF Score
Get the complete analysis for VYYRF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYYRF has been successfully added to your 
